Charles Hart MD
Overview
Dr. Hart received his undergraduate degree from Duke University and his MD degree from the University of Alabama at Birmingham. He performed clinical training in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Florida in Gainesville, FL. He remained on faculty at the University of Florida for two years before moving to Indiana University (IU) in 1990.
At IU he achieved the rank of associate professor of medicine with tenure along with a joint appointment in the Department of Physiology and Biophysics. While at Indiana University, Dr. Hart also became the Pulmonary and Critical Care Fellowship Training Program Director.
In 2000, he was recruited to Emory University and served as the Chief of the Pulmonary Section at the Atlanta VA Medical Center until 2009. He is currently professor of medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine at Emory University, and serves as the Associate Chief of Staff for Research at the Atlanta VA Medical Center and Assistant Dean for VA Research in the Emory School of Medicine.
Dr. Hart has directed a federally-funded research program for over 25 years and has trained over 30 pre-and post-doctoral trainees. A consistent focus of his lab has been on the biology of vascular wall cells and the roles played by reactive oxygen and nitrogen species in vascular health and disease. His recent work has clarified that the nuclear hormone receptor, peroxisome proliferator-activated receptor gamma, plays a critical role in the regulation of vascular function. In addition to directing his research program, Dr. Hart has enjoyed mentoring numerous pre-and post-doctoral trainees as well as junior faculty members in laboratory, has served as the PI of an NIH T32 Training Grant, and has received recognition for his accomplishments in education and mentoring. He also maintains an active clinical practice in Pulmonary and Critical Care Medicine at the Atlanta VA Medical Center.
Academic Appointment
- Assistant Dean for VA Research, Emory School of Medicine
- Graduate Faculty, Molecular Systems Pharmacology Program
- Professor of Medicine, Emory University
Education
Degrees
- MD from University of Alabama in Birmingham
- BS from Duke University
Research
Focus
- Dr. Harts research focuses on vascular endothelial and nitric oxide biology. Major areas of interest include mechanisms by which reactive oxygen and nitrogen species modulate endothelial barrier function, mechanisms of the effects of chronic alcohol ingestion on the lung, and mechanisms by which peroxisome proliferator-activated receptor activation regulates the balanced production of reactive nitrogen and oxygen species in the vasculature.
Publications
-
PPAR/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension.
Pulm Circ Volume: 14 Page(s): e12448
10/01/2024 Authors: Lee DH; Kim M; Chang SS; Lee R; Jang AJ; Kim J; Ma J; Passineau MJ; Benza RL; Karmouty-Quintana H -
LKB1 Regulates Pulmonary Hypertension Endothelial Cell Mitochondria: Another Layer of the Pulmonary Vascular Onion?
Am J Respir Cell Mol Biol Volume: 70 Page(s): 5 - 7
01/01/2024 Authors: Trammell AW; Hart CM -
Pharmacological reversal of post-transcriptional alterations implicated in alcohol-induced alveolar macrophage dysfunction.
Alcohol Volume: 106 Page(s): 30 - 43
02/01/2023 Authors: Yeligar SM; Harris FL; Brown LAS; Hart CM -
The Atlanta VA Health Care System: Morehouse School of Medicine Core Recruiting Site-A Strategy to Increase Diversity in the VA Scientific Workforce.
Health Equity Volume: 7 Page(s): 333 - 337
01/01/2023 Authors: Hart CM; Shepherd KR; Royal W -
Pulmonary hypertension mortality trends in United States 1999-2019.
Ann Epidemiol Volume: 75 Page(s): 47 - 52
08/31/2008 Authors: Kang M; Hart CM; Kempker JA; Veeraraghavan S; Trammell AW -
3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension.
Matrix Biol Volume: 111 Page(s): 53 - 75
03/01/2008 Authors: Tseng V; Collum SD; Allawzi A; Crotty K; Yeligar S; Trammell A; Ryan Smith M; Kang B-Y; Sutliff RL; Ingram JL -
Pulmonary Hypertension: A New Vascular Complication of Diabetes?
Chest Volume: 161 Page(s): 803 - 806
03/01/2022 Authors: Gallini JW; Benkeser D; Cui X; Shah AJ; Phillips LS; Hemnes AR; Hart CM; Trammell AW -
Pioglitazone Reverses Alcohol-Induced Alveolar Macrophage Phagocytic Dysfunction.
J Immunol Volume: 207 Page(s): 483 - 492
07/15/2021 Authors: Yeligar SM; Mehta AJ; Harris FL; Brown LAS; Hart CM -
GLIAL CELL DERIVED NEUROTROPHIC FACTOR PREVENTS PALMITATE-INDUCED OXIDATIVE STRESS AND SUPPRESSION OF MITOPHAGY IN HEPATOCYTES BY INCREASING SIRT3 LEVELS
Volume: 160 Page(s): S64 - S64
05/01/2021 Authors: Mwangi SM; Li G; Chandramowlishwaran P; Liu Y; Hart CM; Merlin D; Czaja MJ; Srinivasan S -
HONOKIOL AND HEXAFLUORO PREVENT CASPASE-11-MEDIATED ENTERIC NEURONAL DEGENERATION THROUGH SIRT3
Volume: 160 Page(s): S132 - S132
05/01/2021 Authors: Chandramowlishwaran P; Li G; Ramanathan A; Raju AV; Mwangi SM; Merlin D; Hart CM; Arbiser J; Srinivasan S